# Mpox: Development of Drugs and Biological Products; Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/mpox-development-of-drugs-and-biological-products-guidance-for-industry/ef1c9a82-c229-49ef-a357-d9947fb4dcdb

> FDA guidance document: Mpox: Development of Drugs and Biological Products; Guidance for Industry. Issue date: January 19, 2023. Get complete insights and analysis.

---

## Details

- Title: Mpox: Development of Drugs and Biological Products; Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2023-01-19
- Comment Close Date: 2023-03-21
- Last Changed: 2023-01-23
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-2395">FDA-2022-D-2395</a>

## Related Documents

- [Clinical Pharmacology Considerations for Peptide Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-pharmacology-considerations-for-peptide-drug-products/1609c8ed-4d50-4235-8a00-9c63176affe8)
- [Psychedelic Drugs: Considerations for Clinical Investigations](https://www.globalkeysolutions.net/guidances/guidance-document/psychedelic-drugs-considerations-for-clinical-investigations/c22c8005-efa9-4373-893d-cf27911562b6)
- [Development of Local Anesthetic Drug Products With Prolonged Duration of Effect](https://www.globalkeysolutions.net/guidances/guidance-document/development-of-local-anesthetic-drug-products-with-prolonged-duration-of-effect/e615d63e-8ed8-401e-a11d-6c93855b2dbd)